ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
- N. Colombo, C. Creutzberg, C. Sessa
- MedicineAnnals of Oncology
- 2 December 2015
Results of this consensus conference on endometrial cancer, together with a summary of evidence supporting each recommendation, are detailed in this article.
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
- N. Concin, X. Matías-Guiu, C. Creutzberg
- MedicineInternational Journal of Gynecological Cancer
- 18 December 2020
A European consensus conference on endometrial carcinoma was held in 2014 to produce multi-disciplinary evidence-based guidelines on selected questions and to cover new topics in order to improve the quality of care for women with endometrian carcinoma across Europe and worldwide.
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- K. Moore, N. Colombo, P. DiSilvestro
- MedicineNew England Journal of Medicine
- 21 October 2018
The use of maintenance therapy with olaparib provided a substantial benefit with regard to progression‐free survival among women with newly diagnosed advanced ovarian cancer and a BRCA1/2 mutation, with a 70% lower risk of disease progression or death with olAParib than with placebo.
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
- J. Ledermann, F. Raja, C. Fotopoulou, A. González-Martín, N. Colombo, C. Sessa
- MedicineAnnals of Oncology
- 1 May 2010
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up N. Colombo, M. Peiretti, G. Parma, M. Lapresa, R. Mancari, S.…
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- R. Coleman, A. Oza, M. Vulfovich
- Medicine, BiologyThe Lancet
- 28 October 2017
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
- N. Colombo, E. Preti, C. Sessa
- MedicineAnnals of Oncology
- 2013
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up N. Colombo, C. Marini & C. Sessa .
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
- N. Colombo, C. Creutzberg, C. Sessa
- MedicineInternational Journal of Gynecologic Cancer
- 12 November 2015
Results of this consensus conference on endometrial cancer, together with a summary of evidence supporting each recommendation, are detailed in this article.
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3…
- E. Pujade-Lauraine, J. Ledermann, P. Pautier
- MedicineThe Lancet Oncology
- 1 September 2017
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.
- M. Parmar, J. Ledermann, C. Tropé
- MedicineThe Lancet
- 2003
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
- N. Colombo, E. Preti, C. Sessa
- MedicineAnnals of Oncology
- 1 September 2011
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up N. Colombo, C. Marini & C. Sessa .
...
...